Tag: communications

Baltimore, MD, Aug. 03, 2025 (GLOBE NEWSWIRE) -- James Altucher examines how Elon Musk’s Starlink network could permanently alter the telecommunications landscape and set the stage for a new era of global connectivity.

Baltimore, MD, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Presentation featuring entrepreneur James Altucher dives into the advanced engineering driving Elon Musk’s Starlink project and how its satellite network could mark a fundamental shift in communications technology.

Baltimore, MD, Aug. 02, 2025 (GLOBE NEWSWIRE) -- A presentation featuring James Altucher examines the engineering and technological breakthroughs behind Elon Musk’s Starlink project, highlighting how satellite architecture and hardware innovation could redefine global internet access.

As the world fixates on cyber warfare, grid instability, and rising tensions in the Middle East, a quieter alarm is sounding beneath the headlines. It doesn’t come from mainstream media, but from former defense insiders and everyday Americans quietly preparing for a different kind of threat — one that won’t announce itself with sirens or headlines. That’s the driving force behind Dark Reset: Survival Before the Silence, a civilian resilience system based on the belief that the next collapse won’t start with fire — it’ll start with silence.

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading business information to the investing public.

DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on August 1, 2025, the Compensation Committee of Taysha's Board of Directors granted one new employee an option to purchase 90,000 shares of the Company's common stock in connection with their employment. The stock option was granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individual entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).

TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV:LMN) announces financial results for the three and six months ended June 30, 2025. All amounts referred to in this press release are in US dollars unless otherwise stated.

Intends to Combine Uniti and Windstream Debt Silos Shortly After Merger Closing

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.